About Acera Surgical
Acera Surgical is a company based in St. Louis (United States) founded in 2013 was acquired by Solventum in November 2025.. Acera Surgical has raised $6.32 million across 5 funding rounds from investors including Solventum, St. Louis Arch Angels and Missouri Technology. Acera Surgical offers products and services including Restrata Sheet, Restrata Meshed 2:1, Restrata MiniMatrix, and Cerafix. Acera Surgical operates in a competitive market with competitors including Adocia, Imbed Biosciences, Humacyte, Organogenesis and Sofregen, among others.
- Headquarter St. Louis, United States
-
Sectors
TechnologyAerospace, Defense & Maritime Healthcare Chemicals & Materials
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Acera Surgical, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Acera Surgical
Acera Surgical offers a comprehensive portfolio of products and services, including Restrata Sheet, Restrata Meshed 2:1, Restrata MiniMatrix, and Cerafix. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Engineered for soft tissue repair in refractory wounds.
Expandable matrix for surgical site coverage.
Dispersible for irregular tissue areas.
Implantable for dural closure and restoration.
Unlock access to complete
Unlock access to complete
Funding Insights of Acera Surgical
Acera Surgical has successfully raised a total of $6.32M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $5.12 million completed in October 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series A — $5.1M
-
First Round
First Round
(05 Jun 2013)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2018 | Amount | Series A - Acera Surgical | Valuation |
investors |
|
| May, 2017 | Amount | Seed - Acera Surgical | Valuation |
investors |
|
| Jun, 2016 | Amount | Seed - Acera Surgical | Valuation | St. Louis Arch Angels |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Acera Surgical
Acera Surgical has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Solventum, St. Louis Arch Angels and Missouri Technology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage businesses are funded by St. Louis Arch Angels.
|
Founded Year | Domain | Location | |
|
Tech companies focused VC firm operating across Missouri
|
Founded Year | Domain | Location | |
|
Innovative medical products and education services are developed and manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Acera Surgical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Acera Surgical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Acera Surgical Comparisons
Competitors of Acera Surgical
Acera Surgical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Imbed Biosciences, Humacyte, Organogenesis and Sofregen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Nanotech-based wound care products are developed and provided.
|
|
| domain | founded_year | HQ Location |
Human tissue-based products are developed for vascular disease applications.
|
|
| domain | founded_year | HQ Location |
Regenerative therapies for wound care are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| domain | founded_year | HQ Location |
Personalized skin tissue therapy is developed by CUTISS for surgeries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Acera Surgical
Frequently Asked Questions about Acera Surgical
When was Acera Surgical founded?
Acera Surgical was founded in 2013.
Where is Acera Surgical located?
Acera Surgical is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.
Is Acera Surgical a funded company?
Acera Surgical is a funded company, having raised a total of $6.32M across 5 funding rounds to date.
What does Acera Surgical do?
Acera Surgical was founded in 2013 in St. Louis, United States, and operates in the regenerative medicine sector. Synthetic biocompatible scaffolds are developed by the company for wound protection and tissue regeneration, featuring porous, fibrous structures made from absorbable polymers. Products include a pliable matrix for tensionless sutures and a sterile covering for defects. FDA clearance has been obtained for these offerings, supporting clinical applications in medical settings.
Who are the top competitors of Acera Surgical?
Acera Surgical's top competitors include Humacyte, Imbed Biosciences and Adocia.
What products or services does Acera Surgical offer?
Acera Surgical offers Restrata Sheet, Restrata Meshed 2:1, Restrata MiniMatrix, and Cerafix.
Who are Acera Surgical's investors?
Acera Surgical has 3 investors. Key investors include Solventum, St. Louis Arch Angels, and Missouri Technology.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.